Case Report: A Lung Adenocarcinoma With Brain Metastasis Harbored Novel MET 14 Skipping Alteration Sensitive to Savolitinib

A splice-site mutation that results in a loss of transcription of exon 14 in the oncogenic driver MET occurs in 3 to 4% of patients with non-small-cell lung cancer (NSCLC). Several MET exon 14 skipping alterations have been identified, but different MET exon splice variants tend to have different cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian, Feng, Yun, Tan, Yuan, Duan, Qianqian, Zhang, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015670/
https://www.ncbi.nlm.nih.gov/pubmed/35444936
http://dx.doi.org/10.3389/fonc.2022.863560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015670/
https://www.ncbi.nlm.nih.gov/pubmed/35444936
http://dx.doi.org/10.3389/fonc.2022.863560

Ejemplares similares